Minnesota biologics regulations.
Who may administer PRP, exosomes and stem cells in Minnesota, and which agencies to check.

Who may administer biologics in Minnesota?
In Minnesota, only licensed healthcare professionals such as a licensed MD/DO other providers need supervising physician's approval to administer treatments.
Official sources
Minnesota compliance guide.
FDA Compliance
In the United States, biologics are regulated under the FDA’s Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P) regulations. Providers must ensure that their use of biologics meets the FDA’s standards under FDA HCT/P Guidelines. These guidelines stipulate specific standards for cell handling, processing, and patient administration to ensure safety and efficacy.
Minnesota State Regulations
Minnesota’s Department of Health oversees the regulation of medical practices, including biologics. To stay compliant, clinics should refer to the Minnesota Department of Health for state-specific requirements and updates. Currently, Minnesota aligns closely with federal standards, requiring adherence to FDA regulations as well as any state-specific licensing and handling rules.
Provider Qualifications
In Minnesota, only licensed healthcare professionals such as a licensed MD/DO other providers need supervising physician's approval to administer treatments. Providers must hold an active state medical license and, depending on the treatment type, may need additional certifications. For more details on licensing, consult the Minnesota Board of Medical Practice.
Patient Informed Consent
Obtaining informed consent is essential in biologic therapies, particularly with stem cell treatments that may still be considered experimental. The consent should outline:
- The potential risks and benefits
- Alternative treatment options
- Acknowledgment of any experimental nature of the therapy. For clear guidance, see Minnesota’s informed consent requirements through the Minnesota Department of Health.
Additional Compliance Steps
Pre-Treatment and Post-Treatment Protocols
Implementing structured pre-treatment assessments and post-treatment follow-ups is crucial. These protocols should include screening for contraindications, assessing patient health status, and following up to monitor outcomes and any adverse effects.
Standard Operating Procedures (SOPs)
Develop SOPs that cover cell storage, handling, and administration protocols. These procedures help maintain compliance and ensure all staff members adhere to standardized practices.
Medical Liability Insurance
Medical liability insurance is recommended for all providers administering biologics. This coverage protects both the clinic and practitioners against potential claims related to biologic treatments.
Marketing Compliance
When advertising biologic treatments, ensure that all claims are supported by evidence and avoid any unsubstantiated promises of outcomes. The FDA has strict guidelines on advertising biologics, so consult the FDA’s marketing guidelines to avoid non-compliant promotions.
This guide is a general summary to help clinics understand compliance requirements for biologics in Minnesota. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.
Minnesota: common questions.
Who can administer stem cells, PRP and exosomes in Minnesota?
Are stem cell and exosome therapies FDA-approved in Minnesota?
Do I need an IRB-approved study to offer biologics in Minnesota?
How do I start offering biologics in Minnesota?
Practising in Minnesota? Start with the webinar.
Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.